Advanced Pharma Clinical Research

Miami, Florida 33175

0 studies enrolling now · 6 studies all time

What they study most

Acute Coronary Syndrome, Healthy, Hepatic Insufficiency, Lupus Erythematosus, Systemic, Metabolic Dysfunction-Associated Steatohepatitis (MASH), Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD), Psoriasis

Studies at this site

• A Single-Ascending and Repeated Dose Study of LY3849891 in Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) — Completed
• A Study of LY3437943 in Participants With Impaired and Normal Liver Function — Completed
• Study of Pirtobrutinib (LOXO-305) in Participants With Impaired Liver Function and Healthy Participants — Completed
• A Safety Study of LY3462817 and LY3509754 in Participants With Psoriasis — Stopped early
• A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus — Stopped early
• Phase III Acute Coronary Syndrome — Stopped early